GIM
MDT icon

Glenmede Investment Management’s Medtronic MDT Stock Holding History

Glenmede Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$48.3M Sell
507,406
-31,401
-6% -$2.89M 0.23% 84
2025
Q2 		$47M Buy
+538,807
New +$45.7M 0.24% 87

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Investment Management's MDT Position: Q3 2025 in Review

Glenmede Investment Management reduced its Medtronic (MDT) stake by 5.8% in Q3 2025, selling an estimated $2.89M and leaving 507,406 shares worth $48.3M. The position accounts for 0.23% of the portfolio, ranked #84.

Glenmede Investment Management first reported a position in MDT in Q2 2025 and has held it in 2 quarters since. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Glenmede Investment Management held 507,406 shares of Medtronic worth $48.3M as of Q3 2025.
  • Glenmede Investment Management sold 31,401 Medtronic shares in Q3 2025, an estimated $2.89M.
  • Medtronic made up 0.23% of Glenmede Investment Management's portfolio in Q3 2025, its #84 holding.
  • Glenmede Investment Management first reported a position in Medtronic in Q2 2025 and has held it in 2 quarters since.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.